Back to search results
Not yet recruiting

Neuroblastoma

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

JZHD | {{ defaultRegistry.registryAnchorText }} NCT04106219 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The reason for this study is to see if the study drug LY3295668 erbumine is safe in participants with relapsed/refractory neuroblastoma.

Time Commitment

Your participation in this trial could last up to 67 months, depending on your cancer type and how you and your tumor responds.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

2 years
21 years

-Participants must have relapsed/refractory neuroblastoma and have active disease in at least one site: bone, bone marrow or soft tissue. Participants must be able to submit an archival sample of tissue

-Participants must be able to swallow capsules

-Participants must not have had more than 3 treatment regimens given after frontline initial therapy

-Participants must not have had prior allogeneic or solid organ transplant

-Participants must not have untreated tumor that has spread to the brain or spinal cord

-Participants must not have a serious active disease other than neuroblastoma

-Participants must not have a condition affecting absorption

-Participants must not have had prior aurora kinase inhibitor exposure

-Participants must not have a known allergy to the study treatment

-Participants must not have symptomatic human immunodeficiency virus (HIV) infection or symptomatic activated/reactivated hepatitis A, B, or C

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is notĀ optimizedĀ for your browser, as configured.